Nicolaus Copernicus and the rapid vascular responses to aldosterone

Trends in Endocrinology and Metabolism

Volumn 26, Issue 8, 2015, Pages 396-398

  Barton, Matthias ^a   Meyer, Matthias R ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Aldosterone; GPR30; Membrane receptor; Non genomic; Steroid receptor

Indexed keywords

ALDOSTERONE; ALDOSTERONE RECEPTOR; ALDOSTERONE SYNTHASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STEROID RECEPTOR; MINERALOCORTICOID RECEPTOR;

BLOOD VESSEL REACTIVITY; CELL MEMBRANE; ENZYME PHOSPHORYLATION; HORMONE ACTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; VASCULAR SMOOTH MUSCLE CELL; CHEMISTRY; HISTORY; PHYSIOLOGY; PUBLIC FIGURE; SCIENCE;

CHEMISTRY; FAMOUS PERSONS; HISTORY, 15TH CENTURY; HISTORY, 16TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, MINERALOCORTICOID; SCIENCE;

EID: 84938292786     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2015.05.005     Document Type: Short Survey

References (21)

1. Rutkowski B., et al. Nicolaus Copernicus: not only a great astronomer but also a physician. J. Nephrol. 2011, 24(Suppl. 17):S25-S32.
2. Benovic J.L. G-protein-coupled receptors signal victory. Cell 2012, 151:1148-1150.
3. Neubig R.R., et al. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology. Pharmacol. Rev. 2003, 55:597-606.
4. Barton M., Prossnitz E.R. Emerging roles of GPER in diabetes and atherosclerosis. Trends Endocrinol. Metab. 2015, 26:185-192.
5. Funder J.W. The genetics of primary aldosteronism. Science 2011, 331:685-686.
6. Gros R., et al. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. Am. J. Physiol. Cell Physiol. 2013, 304:C532-C540.
7. Ren Y., et al. Aldosterone sensitizes connecting tubule glomerular feedback via the aldosterone receptor GPR30. Am. J. Physiol. Renal Physiol. 2014, 307:F427-F434.
8. Brailoiu G.C., et al. Aldosterone increases cardiac vagal tone via G protein-coupled oestrogen receptor activation. J. Physiol. 2013, 591:4223-4235.
9. Fuller P.J. Novel interactions of the mineralocorticoid receptor. Mol. Cell. Endocrinol. 2015, 408:33-37.
10. Gros R., et al. GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone. Hypertension 2011, 57:442-451.
11. Cheng S.B., et al. Anatomical location and redistribution of G protein-coupled estrogen receptor-1 during the estrus cycle in mouse kidney and specific binding to estrogens but not aldosterone. Mol. Cell. Endocrinol. 2014, 382:950-959.
12. Funder J.W., et al. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 1988, 242:583-585.
13. Hatakeyama H., et al. Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J. Biol. Chem. 1994, 269:24316-24320.
14. Caroccia B., et al. GPER-1 and estrogen receptor-beta ligands modulate aldosterone synthesis. Endocrinology 2014, 155:4296-4304.
15. Wendler A., et al. Nongenomic actions of aldosterone and progesterone revisited. Steroids 2012, 77:1002-1006.
16. Grossmann C., et al. Colocalization of mineralocorticoid and EGF receptor at the plasma membrane. Biochim. Biophys. Acta 2010, 1803:584-590.
17. Ziera T., et al. Cnksr3 is a direct mineralocorticoid receptor target gene and plays a key role in the regulation of the epithelial sodium channel. FASEB J. 2009, 23:3936-3946.
18. Wildling L., et al. Aldosterone receptor sites on plasma membrane of human vascular endothelium detected by a mechanical nanosensor. Pflügers Arch. 2009, 458:223-230.
19. Grossmann C., et al. Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions. Mol. Endocrinol. 2005, 19:1697-1710.
20. Coutinho P., et al. Aldosterone's rapid, nongenomic effects are mediated by striatin: a modulator of aldosterone's effect on estrogen action. Endocrinology 2014, 155:2233-2243.
21. Barton M., et al. Estrogen-independent activation of estrogen receptors. Hypertension 2011, 57:1056-1057.